TYPE 1 DIABETES: IMPACT OF SGLT-2 INHIBITORS ON GLYCEMIC CONTROL

被引：0
|
作者：
Lavrador, M. [1 ]
Araujo, B. [1 ]
Araujo, C. [1 ]
Melo, M. [1 ]
Baptista, C. [1 ]
Barros, L. [1 ]
Paiva, I. [1 ]
机构：
[1] Ctr Hosp Univ Coimbra, Endocrinol, Coimbra, Portugal
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP241 / #5
引用
收藏
页码：A181 / A181
页数：1
相关论文
共 50 条
  • [41] SGLT-2 inhibitors and dementia
    Tu, Sung-Yun
    Shao, Shih-Chieh
    Loh, Ching-Hui
    Huang, Huei-Kai
    BMJ-BRITISH MEDICAL JOURNAL, 2024, 386
  • [42] The SGLT-2 Inhibitors in Personalized Therapy of Diabetes Mellitus Patients
    Tilinca, Mariana Cornelia
    Tiuca, Robert Aurelian
    Tilea, Ioan
    Varga, Andreea
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [43] Diabetes, SGLT-2 Inhibitors, and Urinary Tract Infection: a Review
    Pishdad, Reza
    Auwaerter, Paul G.
    Kalyani, Rita R.
    CURRENT DIABETES REPORTS, 2024, 24 (05) : 108 - 117
  • [44] Diabetes, SGLT-2 Inhibitors, and Urinary Tract Infection: a Review
    Reza Pishdad
    Paul G. Auwaerter
    Rita R. Kalyani
    Current Diabetes Reports, 2024, 24 : 108 - 117
  • [45] Diabetes Management and Cardiovascular Risk: Are SGLT-2 Inhibitors the Safest?
    Swislocki, Arthur L. M.
    Jialal, Ishwarlal
    METABOLIC SYNDROME AND RELATED DISORDERS, 2016, 14 (01) : 3 - 6
  • [46] SGLT-2 inhibitors reduce mortality in hospitalized diabetes patients
    Lichert, Frank
    AKTUELLE ERNAHRUNGSMEDIZIN, 2024, 49 (03): : 188 - 189
  • [47] SGLT-2 Inhibitors: Fighting Cardiovascular Disease Mortality in Diabetes
    Ghaffar, Zunaira Abdul
    Anwar, Shahzad
    Rizvi, Syed Wajih
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (02): : 195 - 195
  • [48] Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and the Treatment of Type 2 Diabetes
    Kramer, Caroline K.
    Zinman, Bernard
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 323 - 334
  • [49] GLP-1 Receptor Agonists and SGLT-2 Inhibitors as Adjuncts to Insulin in Type 1 Diabetes: Benefits and Concerns
    Dimitriadis, George D.
    Lambadiari, Vaia
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (04): : E52 - E53
  • [50] Can incretin-based therapy and SGLT-2 inhibitors may be useful in the treatment of diabetes type 1?
    Rozanska, Paulina
    Wierusz-Wysocka, Bogna
    Zozulinska-Ziolkiewicz, Dorota
    CLINICAL DIABETOLOGY, 2015, 4 (04): : 147 - 151
12345